Does UBLITUXIMAB Cause Off label use? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Off label use have been filed in association with UBLITUXIMAB (BRIUMVI). This represents 1.8% of all adverse event reports for UBLITUXIMAB.
28
Reports of Off label use with UBLITUXIMAB
1.8%
of all UBLITUXIMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Off label use From UBLITUXIMAB?
Of the 28 reports, 5 (17.9%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBLITUXIMAB. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does UBLITUXIMAB Cause?
Infusion related reaction (538)
Fatigue (110)
Headache (55)
Inappropriate schedule of product administration (53)
Malaise (49)
Multiple sclerosis relapse (48)
Asthenia (45)
Pain (45)
Illness (43)
Urinary tract infection (42)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which UBLITUXIMAB Alternatives Have Lower Off label use Risk?
UBLITUXIMAB vs UBLITUXIMAB-XIIY
UBLITUXIMAB vs UBROGEPANT
UBLITUXIMAB vs ULIPRISTAL
UBLITUXIMAB vs UMBRALISIB
UBLITUXIMAB vs UMECLIDINIUM